Alflutinib Uses, Dosage, Side Effects and more
Alflutinib is under investigation in clinical trial NCT03452592 (Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients With T790M).
| Trade Name | Alflutinib |
| Generic | Alflutinib |
| Type | |
| Formula | C28H31F3N8O2 |
| Weight | Average: 568.605 Monoisotopic: 568.252206759 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
